Frontlight ResearchEarly access
Pancreatic cancer trials in United States
405 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in United StatesUtilizing Standard of Care Induction Chemotherapy Followed by MR-LINAC Radiotherapy and Surgical Exploration to Improve Resectability Rates in Potentially Resectable Locally Advanced Pancreatic Cancer
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 20
- Run by
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
See details and how to joinNCT07871461 - No phaseTaking peopleTumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
- Where
- Columbia
- Age
- 18 years and over
- People
- 320
- Run by
- University of Missouri-Columbia
See details and how to joinNCT03551951 - Phase 1Taking peoplePhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Princeton
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631 - Phase 1Taking peopleChemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection
- Where
- Omaha
- Age
- 19 years and over
- People
- 15
- Run by
- University of Nebraska
See details and how to joinNCT06320990 - Phase 1Taking peoplePTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
- Where
- Dallas, Detroit, Houston, Lake Success, Miami, Newport Beach, Seattle
- Age
- 18 years and over
- People
- 26 worldwide
- Run by
- PanTher Therapeutics
See details and how to joinNCT06673017 - Phase 2Taking peopleEndoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
- Where
- Houston
- Age
- 18 years and over
- People
- 24
- Run by
- The University of Texas Health Science Center, Houston
See details and how to joinNCT06831136 - Phase 2Not yet taking people in United StatesTrial of First-line Gemcitabine and Nab-paclitaxel With or Without L-glutamine in Advanced Pancreatic Cancer
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 200
- Run by
- Jun Gong, MD
See details and how to joinNCT07864571 - Phase 3Taking peopleGlufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- Where
- Canton, Tampa, Whittier
- Age
- 18 years and over
- People
- 480
- Run by
- Eleison Pharmaceuticals LLC.
See details and how to joinNCT01954992 - Phase 2Taking peopleA Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer
- Where
- Baltimore, San Antonio
- Age
- 18 years and over
- People
- 25
- Run by
- Lei Zheng
See details and how to joinNCT05604560 - Phase 1Taking peopleStudy of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Where
- Boston, Charleston, Charlotte, Cleveland, Houston, La Jolla, Los Angeles, Nashville, New York, Pittsburgh, Providence, Sacramento, Tampa
- Age
- 18 years and over
- People
- 473 worldwide
- Run by
- Bicara Therapeutics
See details and how to joinNCT04429542 - Phase 3Taking peopleExtending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
- Where
- Camden, Dallas, Houston, Voorhees Township
- Age
- 18 years and over
- People
- 80
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06593431 - Early phase 1Taking peopleOMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Portland
- Age
- 18 years and over
- People
- 12
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT07089940 - No phaseTaking peopleDeveloping New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- Where
- Brooklyn, Jamaica, New York, Richmond Hill
- Age
- 18 years and over
- People
- 445
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04751435 - Phase 1/2Taking peopleStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Boston, Chicago, Houston, La Jolla, Los Angeles, New York, Portland, Richmond, San Antonio, San Francisco
- Age
- 18 years to 130 years
- People
- 695 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00 - Phase 2Taking peopleA Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 60
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07283705 - Phase 1Taking peopleAVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- Where
- Chicago, Fairfax, Grand Rapids, Irving, New York, Sarasota, Scottsdale
- Age
- 18 years and over
- People
- 174
- Run by
- Avacta Life Sciences Ltd
See details and how to joinNCT07454642 - Phase 1/2Taking peopleDCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer
- Where
- Columbus
- Age
- 18 years and over
- People
- 50
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT07705919 - Phase 2Taking peopleBMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
- Where
- Jacksonville, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 43
- Run by
- Mayo Clinic
See details and how to joinNCT07226856 - Phase 2Taking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Commack, Houston, Louisville, Orange, Palo Alto, Providence, Santa Rosa
- Age
- 18 years and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - Phase 2Taking peopleGemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
- Where
- Atlanta, Washington D.C.
- Age
- 18 years and over
- People
- 36
- Run by
- Georgetown University
See details and how to joinNCT06423326 - Phase 2Taking peopleThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 27
- Run by
- Mayo Clinic
See details and how to joinNCT07285044 - Phase 2Taking peopleProton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
- Where
- Flint, Jacksonville, Little Rock, Warrenville
- Age
- 18 years and over
- People
- 60
- Run by
- Proton Collaborative Group
See details and how to joinNCT02598349 - Phase 1Taking peopleA Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Where
- Boston, Charlotte, Duarte, Gilbert, Houston, Jacksonville, Los Angeles, Miami, Milwaukee, Nashville, New Brunswick, Newport Beach, New York, Pittsburgh, Portland, Round Rock, Santa Monica, Tampa, Winston-Salem
- Age
- 18 years and over
- People
- 45
- Run by
- AstraZeneca
See details and how to joinNCT05877599 - Phase 1Taking peopleA Study of PHN-012 in Patients With Advanced Solid Tumors
- Where
- Boston, Durham, Fairfax, Houston, Los Angeles, Nashville, Portland, San Antonio, San Diego, St Louis, Washington D.C.
- Age
- 18 years and over
- People
- 165 worldwide
- Run by
- Pheon Therapeutics
See details and how to joinNCT07127874 - No phaseTaking peopleHepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma
- Where
- Orlando
- Age
- 18 years to 80 years
- People
- 10
- Run by
- AdventHealth
See details and how to joinNCT07845617